Docket Room.
H 2472·MA·house

An Act protecting patient safety regarding non-FDA approved drugs

FailedFiled Feb 27, 2025
Sponsor: Kathleen R. LaNatra (D)
Latest Action

Accompanied a study order, see H5234

Mar 16, 2026

Email me when H 2472 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track H 2472. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill forbids any retail pharmacy in Massachusetts from selling compounded medications to anyone other than the patient for whom they were prepared. It also requires detailed labeling on compounded drugs and gives the state pharmacy board authority to fine, suspend, or revoke licenses for violations. The goal is to protect patient safety by ensuring compounded drugs are used only as intended.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about H 2472

3 free questions a day, no account

History

  1. Accompanied a study order, see H5234
  2. Reporting date extended to Thursday, October 9, 2025
  3. Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
  4. Senate concurred
  5. Referred to the committee on Public Health

Sponsors

  • Kathleen R. LaNatra (D) · sponsor
  • Patrick Joseph Kearney

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when H 2472 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track H 2472 free

Or ask your AI assistant about H 2472 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice